How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018

被引：0
|
作者：
A. J. W. M. de Veer
N. Bennaghmouch
W. J. M. Dewilde
J. M. ten Berg
机构：
[1] St. Antonius Hospital,Department of Cardiology
[2] Imelda Hospital,Department of Cardiology
来源：
Netherlands Heart Journal | 2021年 / 29卷
关键词：
Anticoagulation; Antiplatelet therapy; Acute coronary syndrome; Percutaneous coronary intervention; Atrial fibrillation; Non-vitamin K antagonist oral anticoagulants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 141
页数：6
相关论文
共 50 条
  • [41] Long term antithrombotic treatment in atrial fibrillation patients undergoing coronary surgery
    Skibniewski, M.
    Venetsanos, D.
    Janzon, M.
    Karlsson, L.
    Sederholm, S. Lawesson
    Nielsen, S. J.
    Jeppsson, A.
    Alfredsson, J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2953 - 2953
  • [42] In search for an optimal antithrombotic regimen in patients with atrial fibrillation undergoing stenting
    Tantry, Udaya S.
    Chaudhary, Rahul
    Gurbel, Paul A.
    KARDIOLOGIA POLSKA, 2019, 77 (09) : 817 - 819
  • [43] Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry
    Proietti, Marco
    Airaksinen, K. E. Juhani
    Rubboli, Andrea
    Schlitt, Axel
    Kiviniemi, Tuomas
    Karjalainen, Pasi P.
    Lip, Gregory Y.
    CIRCULATION, 2016, 134
  • [44] Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry
    Proietti, Marco
    Airaksinen, K. E. Juhani
    Rubboli, Andrea
    Schlitt, Axel
    Kiviniemi, Tuomas
    Karjalainen, Pasi P.
    Lip, Gregory Y.
    CIRCULATION, 2016, 134
  • [45] Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy
    Fanaroff, Alexander C.
    Lopes, Renato D.
    EUROPEAN HEART JOURNAL, 2020, 41 (47) : 4505 - 4507
  • [46] And now we have the AUGUSTUS ... How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?
    Rubboli, Andrea
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 65 : 1 - 3
  • [47] Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting
    Manzano-Fernandez, Sergio
    Pastro, Francisco J.
    Marin, Francisco
    Cambronero, Francisco
    Caro, Cesar
    Pascual-Figal, Domingo A.
    Garrido, Iris P.
    Pinar, Eduardo
    Valdes, Mariano
    Lip, Gregory Y. H.
    CHEST, 2008, 134 (03) : 559 - 567
  • [48] Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Where Are We Now?
    D'Angelo, Ryan G.
    McGiness, Thaddeus
    Waite, Laura H.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (09) : 884 - 897
  • [49] Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Kuno, Toshiki
    Ueyama, Hiroki
    Takagi, Hisato
    Ando, Tomo
    Numasawa, Yohei
    Briasoulis, Alexandros
    Fox, John
    Bangalore, Sripal
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 521 - 527
  • [50] Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2020, 35 (01) : 44 - 51
12345